Clinical Trials Directory

Trials / Completed

CompletedNCT00213551

Glutamine and Intestinal Protein Metabolism

Comparative Effects of Glutamine and Glucose on Intestinal Protein Metabolism in Healthy Humans

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Gut barrier plays a major role in defence of the organism. During catabolic states, like major surgery or inflammation, gut barrier could be altered. It has been reported that preoperative nutritional support may have beneficial effects on clinical outcome in patients with surgery on gastrointestinal tract. Glutamine, which is a conditionally essential amino, have been reported to modulate inflammatory, antioxidant responses and protein metabolism in intestine. In addition, glutamine supply improves clinical outcome in critically ill patients. Antioxidant micronutrients may also have some beneficial effects in intestine by improving antioxidant response and might also regulate protein expression. Nevertheless, effects of glutamine combined to antioxidant micronutrients have not been evaluated. Thus, the aim of this study will be to assess the influence of glutamine and glutamine-antioxidant micronutrients-containing solutions on intestinal response in humans.

Conditions

Interventions

TypeNameDescription
DRUGGlutamine
DRUGGlucose
DRUGglutamine-antioxidants containing solution

Timeline

Start date
2004-04-01
Completion
2008-06-01
First posted
2005-09-21
Last updated
2013-06-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00213551. Inclusion in this directory is not an endorsement.